Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate

Cancer Research

Volumn 58, Issue 14, 1998, Pages 2957-2960

  Farina, Antonietta R ^a,b   Tacconelli, Antonella ^a   Teti, Anna ^a   Gulino, Alberto ^b,c   Mackay, Andrew R ^a,b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CHELATING AGENT; EDETIC ACID; GELATINASE A; PLASMIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER INVASION; HUMAN; IMMUNOBLOTTING; METASTASIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ALENDRONATE; CATIONS; CHELATING AGENTS; DIPHOSPHONATES; EDETIC ACID; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; PLASMIN; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0032527618     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cottam, D. W., and Rees, R. C. Regulation of matrix metalloproteinases: their role in tumour invasion and metastasis. Int. J. Oncol., 2: 861-872, 1993.
2. Mignatti, P., and Rifkin, D. B. Biology and biochemistry of proteinases in tumour invasion. Physiol. Rev., 73: 161-195, 1993.
3. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner, B. L., Grant, G. A., Seltzer, J. L., Kornberger, A., He, C., Bauer, E. A., and Goldberg, G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem., 263: 6579-6587, 1988.
4. Mackay, A. R., Hartzler, J. L., Pelina, M. D., and Thorgeirsson, U. P. Studies on the ability of 65-kDa and 92-kDa tumour cell gelatinases to degrade type IV collagen. J. Biol. Chem., 265: 21929-21934, 1990.
5. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. Biol. Chem., 264: 17374-17387, 1989.
6. Murphy, G., Willenbrook, F., Ward, R, V., Cockett, M. I., Eaton, D., and Docherty, A. J. P. The C-terminal domain of 72-kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J., 283: 637-641, 1992.
7. Nagase, H. Activation mechanisms of matrix metalloproteinases. Biol. Chem., 378: 151-160, 1997.
8. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50: 6184-6191, 1990.
9. Nagase, H., Suzuki, K., Morodomi, T., Enghild, J. J., and Salvensen, G. Activation mechanisms of the precursor of matrix metalloproteinases 1, 2 and 3. Matrix Suppl., 1: 237-244, 1991.
10. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell bound reactants. EMBO J., 9: 2319-2332, 1997.
11. Tiberio, A., Farina, A. R., Tacconelli, A., Cappabianca, L., Gulino, A., and Mackay, A. R. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator. Int. J. Cancer, 73: 740-748, 1997.
12. Mackay, A. R., Ballin, M., Pelina, M. D., Farina, A. R., Nason, A. M., Hartzler, J. L., and Thorgeirsson, U. P. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumour and normal cell lines. Invasion Metastasis, 12: 168-184, 1992.
13. Fleisch, H. Bisphosphonates. Pharmacology and use in treatment of tumour induced hypercalcaemic and metastatic bone diseases. Drugs, 42: 919-944, 1991.
14. Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., and Rodan, G. A. Bisphosphonate action. Alendronate localisation in rat bone and effects on osteoclast ultrastructure. J. Clin. Invest., 88: 2095-2105, 1991.
15. Teronen, O., Konttinen, Y. T., Lindqvist, C., Salo, T., Ingman, T., Lauhio, A., Ding, Y., Santavirta, S., Valleala, H., and Sorsa, T. Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (Clodronate), Calcif. Tissue Int., 61: 59-61. 1997.
16. Hill, P. A., Docherty, A. J., Bottomly, K. M., O'Connell, J. P., Morphy, J. R., Reynolds, J. J., and Meikle, M. C. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem. J., 308: 167-175, 1995.
17. Teti, A., Farina, A. R., Villanova, I., Tacconelli, A., Sciortino, G., Chambers, A. F., Gulino, A., and Mackay, A. R. Activation of MMP-2 by the human osteoclast containing, giant cell tumor line, GCT23, by osteopontin, bone sialoprotein and GRGDSP peptide is RGD and cell shape change dependent. Int. J. Cancer, in press, 1998.
18. Grignon, D. J., Sakr, W. S., Toth, M., Ravery, V., Angulo, J., Shamsa, F., Pontes, J. E., Crissman, J. C., and Fridman, R. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res., 56: 1654-1659, 1996.
19. Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C. M., Sarkar, F. H., Crissman, J. D., and Fridman, R. Enhanced expression of tissue inhibitor of metalloproteinases 2 (TIMP-2) in the stroma of breast carcinomas correlates with tumour recurrence. Int. J. Cancer, 58: 1-6, 1994.
20. Stongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J. Biol. Chem., 270: 5331-5338, 1995.